In addition, we also assessed the correlations between IFITM3 and the expression of immune checkpoints, including LAG3, TIGIT, CTLA4, CD274, PDCD1, HAVCR2, CD80, and CD86, across cancers. This evidence concerns the gene TIGIT and cancer.